Elite in Cholecystitis

Takao Itoi

Tokyo, JP 
Elite in Cholecystitis
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Takao Itoi practices in Tokyo, Japan. Mr. Itoi is rated as an Elite expert by MediFind in the treatment of Cholecystitis. His top areas of expertise are Cholecystitis, Pancreatic Cancer, Gallbladder Disease, Endoscopy, and Stent Placement.

His clinical research consists of co-authoring 699 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 40 articles in the study of Cholecystitis.

Gender
Male

Locations

Tokyo, Japan
Other Locations
Shinjuku, Japan
Shinjiku, Japan
Minato, 1050004, Japan
Nishishinjuku, 1600023, Japan
Niiza, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Prospective, Multi-center, Randomized Controlled Study Comparing Endoscopic Clearance of Non-Complex Biliary Stones Using Fluoroscopy/Radiation-Free Direct Solitary Cholangioscopy (DSC) to Standard of Care Endoscopic Retrograde Cholangiography (ERC)
Prospective, Multi-center, Randomized Controlled Study Comparing Endoscopic Clearance of Non-Complex Biliary Stones Using Fluoroscopy/Radiation-Free Direct Solitary Cholangioscopy (DSC) to Standard of Care Endoscopic Retrograde Cholangiography (ERC)
Enrollment Status: Completed
Publish Date: January 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures. A Multi-centred Randomised Controlled Trial
EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures. A Multi-centred Randomised Controlled Trial
Enrollment Status: Completed
Publish Date: August 31, 2023
Intervention Type: Procedure
Study Phase: Phase 2/Phase 3
Randomized Multi-Center Study Comparing No Drainage to Preoperative Biliary Drainage Using Metal Stents in Patients With Resectable Pancreatic or Periampullary Cancer
Randomized Multi-Center Study Comparing No Drainage to Preoperative Biliary Drainage Using Metal Stents in Patients With Resectable Pancreatic or Periampullary Cancer
Enrollment Status: Completed
Publish Date: April 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Post Market Survey to Detect Information of Adverse Events and Device Malfunctions of AXIOS Stent and Electrocautery Enhanced Delivery System Under Real World Medical Condition in Japan
A Post Market Survey to Detect Information of Adverse Events and Device Malfunctions of AXIOS Stent and Electrocautery Enhanced Delivery System Under Real World Medical Condition in Japan
Enrollment Status: Completed
Publish Date: March 18, 2022
Intervention Type: Device
A Multicenter Randomized Trial, Comparing EUS Fine Needle Biopsy (EUS-FNB) With Rapid On-Site Evaluation (ROSE) Versus EUS-FNB Alone for the Evaluation of Patients With Solid Pancreatic Lesions
A Multicenter Randomized Trial, Comparing EUS Fine Needle Biopsy (EUS-FNB) With Rapid On-Site Evaluation (ROSE) Versus EUS-FNB Alone for the Evaluation of Patients With Solid Pancreatic Lesions
Enrollment Status: Completed
Publish Date: September 30, 2020
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 4 Less Clinical Trials

699 Total Publications

Endoscopic ultrasound-guided trans-papillary versus trans-luminal biliary stenting: Randomized comparison of long term stent patency.
Endoscopic ultrasound-guided trans-papillary versus trans-luminal biliary stenting: Randomized comparison of long term stent patency.
Journal: Endoscopy
Published: October 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Itoi's expertise for a condition
ConditionClose
View All 16 Distinguished Conditions
View All 23 Advanced Conditions
View All 54 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile